SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193805-11-001023
Filing Date
2011-05-25
Accepted
2011-05-25 17:20:56
Documents
1
Group Members
DEERFIELD CAPITAL, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD PRIVATE DESIGN FUND, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITEDDEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e608512_13da-talon.htm SC 13D/A 388413
  Complete submission text file 0001193805-11-001023.txt   390203
Mailing Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080 650-588-6404
Talon Therapeutics, Inc. (Subject) CIK: 0001140028 (see all company filings)

IRS No.: 320064979 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79910 | Film No.: 11871881
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13D/A